Current Pharmaceutical Design
Title: Editorial [ Carbonic Anhydrases as Drug Targets Executive Editor: Claudiu T. Supuran ]
Volume: 14 Issue: 7
Author(s): Claudiu T. Supuran
Affiliation:
Export Options
About this article
Cite this article as:
Supuran T. Claudiu, Editorial [ Carbonic Anhydrases as Drug Targets Executive Editor: Claudiu T. Supuran ], Current Pharmaceutical Design 2008; 14 (7) . https://dx.doi.org/10.2174/138161208783877910
DOI https://dx.doi.org/10.2174/138161208783877910 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Patents Review in siRNA Delivery for Pulmonary Disorders
Recent Patents on Drug Delivery & Formulation Safety Issues of Vitamin D Supplementation
Anti-Cancer Agents in Medicinal Chemistry Statistical Molecular Design of Balanced Compound Libraries for QSAR Modeling
Current Medicinal Chemistry Management of Adult Active Tuberculosis Disease in Era of HIV Pandemic, Current Practices and Future Perspectives
Infectious Disorders - Drug Targets New Perspectives in Drug Delivery Systems for the Treatment of Tuberculosis
Current Medicinal Chemistry 5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly(ADP-Ribose)Polymerases (PARPs)
Current Medicinal Chemistry The Impact of Dietary Habits and Nutritional Deficiencies in Urban African Patients Living with Heart Failure in Soweto, South Africa – A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Sepsis and Solid Organ Transplantation
Current Drug Targets Reverse Vaccinology to Computationally Screen Antigenic Epitopes as Potential Vaccine Candidates from Clostridium botulinum Strain Hall A
Current Bioinformatics Drug Targets from Human Pathogenic Amoebas: Entamoeba histolytica,Acanthamoeba polyphaga and Naegleria fowleri
Infectious Disorders - Drug Targets Dihydropyrimidinones Scaffold as a Promising Nucleus for Synthetic Profile and Various Therapeutic Targets: A Review
Current Organic Synthesis New Approaches to Drug-DNA Interactions Based on Graphical Representation and Numerical Characterization of DNA Sequences
Current Computer-Aided Drug Design Nanodelivery Systems for Mucosal Vaccines
Recent Patents on Nanomedicine Rip2: A Key Molecule that Regulates both Innate and Acquired Immunity
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Inter-Species/Host-Parasite Protein Interaction Predictions Reviewed
Current Bioinformatics Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile
Current Drug Safety Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer
Current Cancer Drug Targets Thiazolides, a Novel Class of Anti-Infective Drugs, Effective Against Viruses, Bacteria, Intracellular and Extracellular Protozoan Parasites and Proliferating Mammalian Cells
Anti-Infective Agents Role of Galectins in Allergic Disorders
Recent Patents on Inflammation & Allergy Drug Discovery QSAR Studies on NTF1836 Analogues as Mycothiol Biosynthesis Inhibitors
Letters in Drug Design & Discovery